Most Viewed Top Rated Last Added Last Commented Advanced search Description Tag Title Author Category Mature B-cell neoplasms . |_ Follicular lymphoma . |_ Chronic lymphocytic leukaemia/small lymphocytic lymphoma . |_ B-cell prolymphocytic leukaemia . |_ Splenic marginal zone lymphoma . |_ Hairy cell leukaemia . |_ Splenic lymphoma/leukaemia; unclassifiable . |_ Splenic diffuse red pulp small B-cell lymphoma . |_ Hairy cell leukaemia-variant . |_ Lymphoplasmacytic lymphoma . |_ Waldenström’s macroglobulinemia . |_ Heavy chain diseases . |_ Alpha heavy chain disease . |_ Gamma heavy chain disease . |_ Mu heavy chain disease . |_ Plasma cell myeloma . |_ Solitary plasmacytoma of bone . |_ Extraosseous plasmacytoma . |_ Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) . |_ Nodal marginal zone lymphoma . |_ Paediatric nodal marginal zone lymphoma . |_ Paediatric follicular lymphoma . |_ Primary cutaneous follicle centre lymphoma . |_ Mantle cell lymphoma . |_ Diffuse large B-cell lymphoma (DLBCL); NOS . |_ T-cell/histiocyte rich large B-cell lymphoma . |_ Primary DLBCL of the CNS . |_ Primary cutaneous DLBCL; leg type . |_ EBV positive DLBCL of the elderly . |_ DLBCL associated with chronic inflammation . |_ Lymphomatoid granulomatosis . |_ Primary mediastinal (thymic) large B-cell lymphoma . |_ Intravascular large B-cell lymphoma . |_ ALK positive DLBCL . |_ Plasmablastic lymphoma . |_ Large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease . |_ Primary effusion lymphoma . |_ Burkitt lymphoma . |_ B-cell lymphoma; unclassifiable; with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma . |_ B-cell lymphoma; unclassifiable; with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma Myeloproliferative neoplasms . |_ Chronic myelogenous leukaemia; BCR-ABL1 positive . |_ Chronic neutrophilic leukaemia . |_ Polycythaemia vera . |_ Primary myelofibrosis . |_ Essential thrombocythaemia . |_ Chronic eosinophilic leukaemia;NOS Mastocytosis . |_ Cutaneous mastocytosis . |_ Systemic mastocytosis . |_ Mast cell leukaemia . |_ Mast cell sarcoma . |_ Extracutaneous mastocytoma . |_ Myeloproliferative neoplasm; unclassifiable Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1 . |_ Myeloid and lymphoid neoplasms with PDGFRA rearrangement . |_ Myeloid neoplasms with PDGFRB rearrangement . |_ Myeloid and lymphoid neoplasms with FGFR1 abnormalities Myelodysplastic / myeloproliferative neoplasms . |_ Chronic myelomonocytic leukaemia . |_ Atypical chronic myeloid leukaemia; BCR-ABL1 negative . |_ Juvenile myelomonocytic leukaemia . |_ Myelodysplastic/myeloproliferative neoplasm; unclassifiable . |_ Refractory anaemia with ring sideroblasts associated with marked thrombocytosis Myelodysplastic syndromes . |_ Refractory cytopenia with unilineage dysplasia . |_ Refractory anaemia . |_ Refractory neutropenia . |_ Refractory thrombocytopenia . |_ Refractory anaemia with ring sideroblasts . |_ Refractory cytopenia with multilineage dysplasia . |_ Refractory anaemia with excess blasts . |_ Myelodysplastic syndromes associated with isolated del(5q) . |_ Myelodysplastic syndromes; unclassifiable . |_ Refractory cytopenia of childhood Acute myeloid leukaemia (aml) and related precursor neoplasms . |_ AML with recurrent genetic abnormalities . |_ AML with t(8;21)(q22;q22); RUNX1-RUNX1T1 . |_ AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 . |_ Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA . |_ AML with t(9;11)(p22;q23); MLLT3-MLL . |_ AML with t(6;9)(p23;q34); DEK- NUP214 . |_ AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1 . |_ AML (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1 . |_ AML with mutated NPM1 . |_ AML with mutated CEBPA . |_ AML with myelodysplasia-related changes . |_ Therapy-related myeloid neoplasms . |_ Acute myeloid leukaemia; NOS . |_ AML with minimal differentiation . |_ AML without maturation . |_ AML with maturation . |_ Acute myelomonocytic leukaemia . |_ Acute monoblastic and monocytic leukaemia . |_ Acute erythroid leukaemia . |_ Acute megakaryoblastic leukaemia . |_ Acute basophilic leukaemia . |_ Acute panmyelosis with myelofibrosis . |_ Myeloid sarcoma Myeloid proliferations related to Down syndrome . |_ Transient abnormal myelopoiesis . |_ Myeloid leukaemia associated with Down syndrome . |_ Blastic plasmacytoid dendritic cell neoplasm Acute leukaemias of ambiguous lineage . |_ Mixed phenotype acute leukaemia with t(9;22)(q34;q11.2); BCR-ABL . |_ Mixed phenotype acute leukaemia with t(v;11q23); MLL rearranged . |_ Mixed phenotype acute leukaemia; B/myeloid; NOS . |_ Mixed phenotype acute leukaemia; T/myeloid . |_ Mixed phenotype acute leukaemia; T/myeloid; NOS (2) . |_ Acute undifferentiated leukaemia Precursor lymphoid neoplasms . |_ B lymphoblastic leukaemia/lymphoma . |_ B lymphoblastic leukaemia/lymphoma; NOS . |_ B lymphoblastic leukaemia/lymphoma with recurrent genetic abnormalities . |_ B lymphoblastic leukaemia/lymphoma with t(9;22)(q34;q11.2); BCR-ABL1 . |_ B lymphoblastic leukaemia/lymphoma with t(v;11q23); MLL rearranged . |_ B lymphoblastic leukaemia/lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1) . |_ B lymphoblastic leukaemia/lymphoma with hyperdiploidy . |_ B lymphoblastic leukaemia/lymphoma with hypodiploidy (hypodiploid ALL) . |_ B lymphoblastic leukaemia/lymphoma with t(5;14)(q31;q32); IL3-IGH . |_ B lymphoblastic leukaemia/lymphoma with t(1;19)(q23;p13.3); E2A-PBX1; (TCF3-PBX1) . |_ T lymphoblastic leukaemia/lymphoma Mature T-cell and NK-cell neoplasms . |_ T-cell prolymphocytic leukaemia . |_ T-cell large granular lymphocytic leukaemia . |_ Chronic lymphoproliferative disorder of NK-cells . |_ Aggressive NK cell leukaemia . |_ Systemic EBV positive T-cell lymphoproliferative disease of childhood . |_ Hydroa vaccineforme-like lymphoma . |_ Adult T-cell leukaemia/lymphoma . |_ Extranodal NK/T cell lymphoma; nasal type . |_ Enteropathy-associated T-cell lymphoma . |_ Hepatosplenic T-cell lymphoma . |_ Subcutaneous panniculitis-like T-cell lymphoma . |_ Mycosis fungoides . |_ Sézary syndrome Primary cutaneous CD30 positive T-cell lymphoproliferative disorders . |_ Lymphomatoid papulosis . |_ Primary cutaneous anaplastic large cell lymphoma . |_ Primary cutaneous gamma-delta T-cell lymphoma . |_ Primary cutaneous CD8 positive aggressive epidermotropic cytotoxic T-cell lymphoma . |_ Primary cutaneous CD4 positive small/medium T-cell lymphoma . |_ Peripheral T-cell lymphoma; NOS . |_ Angioimmunoblastic T-cell lymphoma . |_ Anaplastic large cell lymphoma; ALK positive . |_ Anaplastic large cell lymphoma; ALK negative Hodgkin lymphoma . |_ Nodular lymphocyte predominant Hodgkin lymphoma . |_ Classical Hodgkin lymphoma . |_ Nodular sclerosis classical Hodgkin lymphoma . |_ Lymphocyte-rich classical Hodgkin lymphoma . |_ Mixed cellularity classical Hodgkin lymphoma . |_ Lymphocyte depleted classical Hodgkin lymphoma Histiocytic and dendritic cell neoplasms . |_ Histiocytic sarcoma . |_ Langerhans cell histiocytosis . |_ Langerhans cell sarcoma . |_ Interdigitating dendritic cell sarcoma . |_ Follicular dendritic cell sarcoma . |_ Fibroblastic reticular cell tumour . |_ Indeterminate dendritic cell tumour . |_ Disseminated juvenile xanthogranuloma Post-transplant lymphoproliferative disorders (PTLD) . |_ Early lesions . |_ Plasmacytic hyperplasia . |_ Infectious mononucleosis-like PTLD . |_ Polymorphic PTLD . |_ Monomorphic PTLD (B- and T/NK-cell types)* . |_ Classical Hodgkin lymphoma type PTLD* NOS, not otherwise specified PATOLOGIA OGÓLNA CZĘŚĆ 1 PATOLOGIA OGÓLNA CZĘŚĆ 2 Date range From to Search Reset | Hide advance search panel
